The National Living Donor Assistance Center (NLDAC) produces dramatic federal savings through financial support for lower-income kidney donors

For each American who has kidney failure, the Centers for Medicare & Medicaid Services (CMS) spends more than $80,000 per year for dialysis treatment. This cost drops to only $30,000 when a patient receives a kidney transplant and no longer needs dialysis.

Uptake of Generic vs Brand Name Immunosuppressants Among US Organ Transplant Recipients

After an organ transplant, a transplant recipient must take immunosuppressive medications to reduce the risk of their body rejecting the transplanted organ. Although using therapeutically equivalent generic medications can reduce financial burden, the transplant community has expressed caution about substituting these for brand-name immunosuppressants.

Long-term kidney transplant failure rates worse in United States compared to other countries

The best option for people with end-stage kidney disease is to receive a kidney transplant. Kidney transplantation is currently performed in nearly 100 countries, and yet failure of the transplanted kidney in the long term remains an important limitation. Are there differences across countries in the rates of kidney transplant failure?

eGFR level alone may tell little about true timing of dialysis initiation

The United States Renal Data System (USRDS) has often been used to study the timing of dialysis initiation, measured by estimated glomerular filtration rate (eGFR) at dialysis initiation. However, it is not clear how well this information explains the eGFR variation at dialysis initiation, nor how well eGFR serves as a measure for the timing of dialysis initiation. Researchers examined these questions using USRDS data for nearly one million patients who started dialysis between 1995 and 2012.

Can changes in Medicare payments reduce potential disparities in peritoneal dialysis?

Recent policy changes have affected the way that Medicare pays for dialysis, with the goal of improving the overall quality and efficiency of care. As with any new health care payment model, there is a need to determine whether these changes affect health disparities. Does the new model inadvertently lead to worse outcomes for some patients, or does it create new incentives for providers to help overcome barriers to care? In a paper published in Health Services Research, investigators evaluated the effect of these recent Medicare changes on potential disparities in the use of one type of dialysis: peritoneal dialysis.


Featured Articles